Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
The fund outperformed its benchmark in Q4 2025, buoyed by solid healthcare diagnostic and medical technology earnings, while maintaining a constructive medium-term outlook on AI, cloud, and fiscal CapEx catalysts.
Full Quick Take
The fund outperformed its benchmark in Q4 2025, buoyed by solid healthcare diagnostic and medical technology earnings, while maintaining a constructive medium-term outlook on AI, cloud, and fiscal CapEx catalysts.
